RPL22 and colorectal carcinoma: Interestingly, shallow deletion of RPL22 (likely Rpl22+/-) was observed in 36% of CRC patients, which led us to explore its role in CRC (S1A Fig) (http://www.cbioportal.org/index.do?session_id=5a050a4c498e5df2e29800d3) [19].